On
The following tables present selected financial data from 2013 and 2012.
Years Ended December 31, |
|||||||
(in thousands, except per share amounts) |
2013 |
2012 |
|||||
Net income to shareholders |
$ |
281,021 |
$ |
253,385 |
|||
Comprehensive income to shareholders |
$ |
459,489 |
$ |
503,802 |
|||
Weighted average diluted shares |
12,586 |
9,666 |
|||||
Diluted net income per share |
$ |
22.48 |
$ |
25.89 |
|||
(in thousands, except per share amounts) |
December 31, 2013 |
December 31, 2012 |
|||||
Book value per common share outstanding |
$ |
477.16 |
$ |
403.85 |
|||
Common shares outstanding |
13,986 |
9,629 |
The increase in net income to shareholders during 2013 was driven by more favorable underwriting results and higher investment income, partially offset by higher income tax expense compared to 2012. The decrease in diluted net income per share during 2013 was due to the increase in weighted average diluted shares outstanding, which is attributable to shares issued in connection with the acquisition of Alterra.
Comprehensive income to shareholders for 2013 was
Combined Ratio Analysis |
|||
Years Ended December 31, |
|||
2013 |
2012 |
||
Excess and Surplus Lines |
80% |
94% |
|
Specialty Admitted |
97% |
108% |
|
London Insurance Market |
88% |
89% |
|
Alterra |
118% |
—% |
|
Consolidated |
97% |
97% |
The consolidated combined ratio was 97% in both 2013 and 2012. In 2013, a lower current accident year loss ratio and lower expense ratio were offset by a less favorable prior accident years' loss ratio compared to 2012.
The decrease in the consolidated current accident year loss ratio was due in part to the impact of catastrophes in 2012 and improved underwriting results within our Specialty Admitted segment in 2013 compared to 2012, partially offset by an unfavorable impact from Alterra's current year losses. The 2012 combined ratio included
The 2013 combined ratio included
The decrease in the consolidated expense ratio in 2013 reflected higher earned premiums in our Excess and Surplus Lines, Specialty Admitted and London Insurance Market segments in 2013 compared to 2012. The impact of transaction and other acquisition-related costs incurred by the Alterra segment in 2013 was offset by the impact of prospective adoption of Financial Accounting Standards Board Accounting Standards Update No. 2010-26, Accounting for Costs Associated with Acquiring or Renewing Insurance Contracts (ASU No. 2010-26), in 2012. Underwriting, acquisition and insurance expenses included transaction and other acquisition-related costs of
The Excess and Surplus Lines segment's combined ratio for 2013 was 80% compared to 94% (including five points of underwriting loss related to Hurricane Sandy) in 2012. The decrease in the 2013 combined ratio was due to a lower current accident year loss ratio, more favorable development of prior years' loss reserves and a lower expense ratio compared to 2012. The improvement in the current accident year loss ratio in 2013 reflected the impact of losses related to Hurricane Sandy in 2012. The Excess and Surplus Lines segment's 2013 combined ratio included
The Specialty Admitted segment's combined ratio for 2013 was 97% compared to 108% (including three points of underwriting loss related to Hurricane Sandy) in 2012. The decrease in the 2013 combined ratio was primarily due to a lower current accident year loss ratio compared to 2012. The lower current accident year loss ratio in 2013 reflected more favorable rates on our workers' compensation business and a higher proportion of non-
The London Insurance Market segment's combined ratio for 2013 was 88% compared to 89% (including six points of underwriting loss related to Hurricane Sandy) in 2012. The impact of Hurricane Sandy on the 2012 combined ratio was offset by less favorable development of prior years' loss reserves in 2013 compared to 2012. The London Insurance Market segment's 2013 combined ratio included
Following the acquisition of Alterra on
Beginning in 2014, we will monitor and report our ongoing underwriting operations in the following three segments:
Premium Analysis |
|||||||||||||||
Years Ended December 31, |
|||||||||||||||
Gross Written Premiums |
Earned Premiums |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Excess and Surplus Lines |
$ |
1,070,520 |
$ |
956,273 |
$ |
856,629 |
$ |
793,159 |
|||||||
Specialty Admitted |
899,996 |
669,692 |
744,993 |
588,758 |
|||||||||||
London Insurance Market |
914,480 |
887,720 |
781,637 |
765,216 |
|||||||||||
Alterra |
1,035,190 |
— |
848,317 |
— |
|||||||||||
Other Insurance (Discontinued Lines) |
40 |
(4) |
40 |
(5) |
|||||||||||
Total |
$ |
3,920,226 |
$ |
2,513,681 |
$ |
3,231,616 |
$ |
2,147,128 |
Gross written premiums for 2013 increased 56% compared to 2012. The increase in gross premium volume was primarily attributable to the inclusion of premiums written by the Alterra segment from
During 2012 and 2013, we have generally seen low to mid-single digit favorable rate changes in many of our product lines as market conditions improved and revenues, gross receipts and payrolls of our insureds were favorably impacted by improving economic conditions; however, during the fourth quarter of 2013, we began to experience softening prices on our catastrophe exposed property product lines and in our reinsurance book. We will continue to pursue price increases in 2014 when possible; however, when we believe the prevailing market price will not support our underwriting profit targets, the business is not written. As a result of our underwriting discipline, gross premium volume may vary when we alter our product offerings to maintain or improve underwriting profitability.
Net retention of gross premium volume was 83% for 2013 and 88% for 2012. The decrease in net retention in 2013 was due to the inclusion of premiums written by the Alterra segment, which uses higher levels of reinsurance than we have used historically. Net retention of gross premium volume in the Alterra segment was 65% for the period from
Earned premiums for 2013 increased 51% compared to 2012. The increase was primarily attributable to the inclusion of premiums earned by the Alterra segment and higher earned premiums in the Specialty Admitted and Excess and Surplus Lines segments. In 2013, the Specialty Admitted segment included
Net investment income for 2013 was
Net realized investment gains for 2013 were
Other revenues and other expenses include the results of
Invested assets were
At
Net cash provided by operating activities was
Interest expense for 2013 was
Income tax expense for 2013 was 22% of our income before income taxes compared to 17% in 2012. In both periods, the effective tax rate differs from the statutory tax rate of 35% primarily as a result of tax-exempt investment income. The increase in the effective tax rate in 2013 was driven by higher earnings taxed at a 35% tax rate and a smaller tax benefit related to tax-exempt investment income, which resulted from having higher income before income taxes in 2013 compared to 2012.
In
This release contains statements concerning or incorporating our expectations, assumptions, plans, objectives, future financial or operating performance and other statements that are not historical facts. These statements are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may use words such as "anticipate," "believe,' "estimate,' "expect," "intend," "predict," "project" and similar expressions as they relate to us or our management.
There are risks and uncertainties that may cause actual results to differ materially from predicted results in forward-looking statements. Factors that may cause actual results to differ are often presented with the forward-looking statements themselves. Additional factors that could cause actual results to differ from those predicted are set forth under "Risk Factors" and "Safe Harbor and Cautionary Statement" in our 2012 Annual Report on Form 10-K and most recent Quarterly Report on Form 10-Q or are included in the items listed below:
- our anticipated premium volume is based on current knowledge and assumes no significant man-made or natural catastrophes, no significant changes in products or personnel and no adverse changes in market conditions;
- the effect of cyclical trends, including demand and pricing in the insurance and reinsurance markets;
- actions by competitors, including consolidation, and the effect of competition on market trends and pricing;
- we offer insurance and reinsurance coverage against terrorist acts in connection with some of our programs, and in other instances we are legally required to offer terrorism insurance; in both circumstances, we actively manage our exposure, but if there is a covered terrorist attack, we could sustain material losses;
- the frequency and severity of man-made and natural catastrophes (including earthquakes and weather-related catastrophes) may exceed expectations, are unpredictable and, in the case of weather-related catastrophes, may be exacerbated if, as many forecast, conditions in the oceans and atmosphere result in increased hurricane or other adverse weather-related activity;
- emerging claim and coverage issues, changing legal and social trends, and inherent uncertainties (including but not limited to those uncertainties associated with our asbestos and environmental reserves) in the loss estimation process can adversely impact the adequacy of loss reserves and the allowance for reinsurance recoverables;
- reinsurance reserves are subject to greater uncertainty than insurance reserves primarily because of reliance upon the original underwriting decisions made by ceding companies and the longer lapse of time from the occurrence of loss events to their reporting to the reinsurer for ultimate resolution;
- changes in the assumptions and estimates used in establishing reserves for Alterra's life and annuity reinsurance book (which is in runoff), for example, mortality, longevity, morbidity and interest rates, could result in material increases in our estimated loss reserves for such business;
- adverse developments in insurance coverage litigation or other legal or administrative proceedings could result in material increases in our estimates of loss reserves;
- the failure of any loss limitation methods employed;
- changes in the availability, costs and quality of reinsurance coverage which may impact our ability to write certain lines of business;
- industry and economic conditions can affect the ability and/or willingness of reinsurers to pay balances due;
- after the commutation of ceded reinsurance contracts, any subsequent adverse development in the re-assumed loss reserves will result in a charge to earnings;
- regulatory actions can impede our ability to charge adequate rates and efficiently allocate capital;
- economic conditions, actual or potential defaults in sovereign debt obligations, volatility in interest and foreign currency exchange rates and changes in market value of concentrated investments can have a significant impact on the fair value of fixed maturities and equity securities, as well as the carrying value of other assets and liabilities, and this impact may be heightened by market volatility;
- economic conditions; changes in government support for education, healthcare and infrastructure projects; changes in capital spending levels; changes in the housing market; and foreign currency exchange rates, among other factors, may adversely affect the markets served by our
Markel Ventures operations and negatively impact their revenues and profitability; - economic conditions may adversely affect access to capital and credit markets;
- we have substantial investments in municipal bonds (approximately
$3.1 billion at December 31, 2013) and, although no more than 10% of our municipal bond portfolio is tied to any one state, widespread defaults could adversely affect our results of operations and financial condition; - we cannot predict the extent and duration of the current period of slow economic growth; the continuing effects of government intervention into the markets to address the financial crisis of 2008 and 2009 (including, among other things, the effects of the Dodd-Frank Wall Street Reform and Consumer Protection Act and regulations adopted thereunder); the outcome of economic and currency concerns in the Eurozone; material changes to the monetary policies of the U.S. Federal Reserve; and their combined impact on our industry, business and investment portfolio;
- we cannot predict the impact of the implementation of U.S. health care reform legislation and regulations under that legislation on our business;
- our business is dependent upon the successful functioning and security of our computer systems; if our information technology systems fail or suffer a security breach, our business or reputation could be adversely impacted;
- we have recently completed a number of acquisitions, the most significant of which was our 2013 acquisition of Alterra, and may engage in additional acquisition activity in the future, which may increase operational and control risks for a period of time;
- the amount of the costs and charges related to our acquisition and integration of Alterra and related restructuring may exceed our expectations;
- we may not realize the contemplated benefits, including cost savings and synergies, of our acquisitions, including those anticipated from the acquisition of Alterra and related restructuring;
- any determination requiring the write-off of a significant portion of our goodwill and intangible assets, including
$295.7 million and$207.5 million , respectively, recorded in connection with the acquisition of Alterra; - loss of services of any executive officers or other key personnel could impact our operations;
- our expanding international operations expose us to increased investment, political and economic risks, including foreign currency and credit risk; and
- adverse changes in our assigned financial strength or debt ratings could impact our ability to attract and retain business or obtain capital.
Our premium volume, underwriting and investment results and results from our non-insurance operations have been and will continue to be potentially materially affected by these factors. By making forward-looking statements, we do not intend to become obligated to publicly update or revise any such statements whether as a result of new information, future events or other changes. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as at their dates.
Our previously announced conference call, which will involve discussion of our financial results and business developments and may include forward-looking information, will be held
Markel Corporation and Subsidiaries |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands, except per share data) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
OPERATING REVENUES |
|||||||||||||||
Earned premiums |
$ |
962,487 |
$ |
573,939 |
$ |
3,231,616 |
$ |
2,147,128 |
|||||||
Net investment income |
88,585 |
74,273 |
317,373 |
282,107 |
|||||||||||
Net realized investment gains: |
|||||||||||||||
Other-than-temporary impairment losses |
(117) |
(7,927) |
(4,706) |
(12,078) |
|||||||||||
Net realized investment gains, excluding other-than-temporary impairment losses |
22,568 |
14,164 |
67,858 |
43,671 |
|||||||||||
Net realized investment gains |
22,451 |
6,237 |
63,152 |
31,593 |
|||||||||||
Other revenues |
206,262 |
153,506 |
710,942 |
539,284 |
|||||||||||
Total Operating Revenues |
1,279,785 |
807,955 |
4,323,083 |
3,000,112 |
|||||||||||
OPERATING EXPENSES |
|||||||||||||||
Losses and loss adjustment expenses |
552,599 |
340,994 |
1,816,273 |
1,154,068 |
|||||||||||
Underwriting, acquisition and insurance expenses |
368,418 |
234,150 |
1,312,312 |
929,472 |
|||||||||||
Amortization of intangible assets |
17,468 |
8,434 |
55,223 |
33,512 |
|||||||||||
Other expenses |
203,886 |
134,786 |
663,528 |
478,248 |
|||||||||||
Total Operating Expenses |
1,142,371 |
718,364 |
3,847,336 |
2,595,300 |
|||||||||||
Operating Income |
137,414 |
89,591 |
475,747 |
404,812 |
|||||||||||
Interest expense |
31,250 |
23,694 |
114,004 |
92,762 |
|||||||||||
Income Before Income Taxes |
106,164 |
65,897 |
361,743 |
312,050 |
|||||||||||
Income tax expense |
7,225 |
7,804 |
77,898 |
53,802 |
|||||||||||
Net Income |
98,939 |
58,093 |
283,845 |
258,248 |
|||||||||||
Net income attributable to noncontrolling interests |
175 |
1,301 |
2,824 |
4,863 |
|||||||||||
Net Income to Shareholders |
$ |
98,764 |
$ |
56,792 |
$ |
281,021 |
$ |
253,385 |
|||||||
OTHER COMPREHENSIVE INCOME |
|||||||||||||||
Change in net unrealized gains on investments, net of taxes: |
|||||||||||||||
Net holding gains arising during the period |
$ |
118,072 |
$ |
20,369 |
$ |
225,545 |
$ |
266,425 |
|||||||
Change in unrealized other-than-temporary impairment losses on |
(101) |
(24) |
(141) |
(160) |
|||||||||||
Reclassification adjustments for net gains included in net income |
(12,964) |
(3,897) |
(40,830) |
(24,051) |
|||||||||||
Change in net unrealized gains on investments, net of taxes |
105,007 |
16,448 |
184,574 |
242,214 |
|||||||||||
Change in foreign currency translation adjustments, net of taxes |
(212) |
(1,393) |
(10,143) |
1,534 |
|||||||||||
Change in net actuarial pension loss, net of taxes |
2,919 |
5,177 |
4,065 |
6,664 |
|||||||||||
Total Other Comprehensive Income |
107,714 |
20,232 |
178,496 |
250,412 |
|||||||||||
Comprehensive Income |
206,653 |
78,325 |
462,341 |
508,660 |
|||||||||||
Comprehensive income attributable to noncontrolling interests |
203 |
1,338 |
2,852 |
4,858 |
|||||||||||
Comprehensive Income to Shareholders |
$ |
206,450 |
$ |
76,987 |
$ |
459,489 |
$ |
503,802 |
|||||||
NET INCOME PER SHARE |
|||||||||||||||
Basic |
$ |
6.98 |
$ |
6.25 |
$ |
22.57 |
$ |
25.96 |
|||||||
Diluted |
$ |
6.95 |
$ |
6.23 |
$ |
22.48 |
$ |
25.89 |
|||||||
Selected Data |
December 31, |
||||||||||||||
(dollars and shares in thousands, except per share data) |
2013 |
2012 |
|||||||||||||
Total investments, cash and cash equivalents and restricted cash and |
$ |
17,612,074 |
$ |
9,332,745 |
|||||||||||
Reinsurance recoverable on paid and unpaid losses |
1,956,416 |
829,919 |
|||||||||||||
Goodwill |
967,717 |
674,930 |
|||||||||||||
Intangible assets |
565,083 |
374,295 |
|||||||||||||
Unpaid losses and loss adjustment expenses |
10,262,056 |
5,371,426 |
|||||||||||||
Unearned premiums |
2,127,115 |
1,000,261 |
|||||||||||||
Senior long-term debt and other debt |
2,256,227 |
1,492,550 |
|||||||||||||
Total shareholders' equity |
6,673,577 |
3,888,657 |
|||||||||||||
Book value per common share outstanding |
$ |
477.16 |
$ |
403.85 |
|||||||||||
Common shares outstanding |
13,986 |
9,629 |
Markel Corporation and Subsidiaries |
|||||||||||||||
Supplemental Financial Information |
|||||||||||||||
For the Quarters and Years Ended December 31, 2013 and 2012 |
|||||||||||||||
Underwriting Segment Gross Written Premiums |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Excess and Surplus Lines |
$ |
277,643 |
$ |
250,424 |
$ |
1,070,520 |
$ |
956,273 |
|||||||
Specialty Admitted |
212,327 |
173,673 |
899,996 |
669,692 |
|||||||||||
London Insurance Market |
189,327 |
183,209 |
914,480 |
887,720 |
|||||||||||
Alterra |
320,346 |
— |
1,035,190 |
— |
|||||||||||
Other Insurance (Discontinued Lines) |
5 |
2 |
40 |
(4) |
|||||||||||
Consolidated |
$ |
999,648 |
$ |
607,308 |
$ |
3,920,226 |
$ |
2,513,681 |
|||||||
Underwriting Segment Net Written Premiums |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Excess and Surplus Lines |
$ |
238,129 |
$ |
213,859 |
$ |
911,870 |
$ |
811,601 |
|||||||
Specialty Admitted |
200,031 |
160,425 |
855,381 |
628,147 |
|||||||||||
London Insurance Market |
157,978 |
152,436 |
792,158 |
774,383 |
|||||||||||
Alterra |
207,339 |
— |
677,233 |
— |
|||||||||||
Other Insurance (Discontinued Lines) |
6 |
2 |
41 |
(5) |
|||||||||||
Consolidated |
$ |
803,483 |
$ |
526,722 |
$ |
3,236,683 |
$ |
2,214,126 |
|||||||
Underwriting Segment Net Earned Premiums |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Excess and Surplus Lines |
$ |
227,341 |
$ |
208,635 |
$ |
856,629 |
$ |
793,159 |
|||||||
Specialty Admitted |
211,956 |
157,579 |
744,993 |
588,758 |
|||||||||||
London Insurance Market |
204,536 |
207,723 |
781,637 |
765,216 |
|||||||||||
Alterra |
318,649 |
— |
848,317 |
— |
|||||||||||
Other Insurance (Discontinued Lines) |
5 |
2 |
40 |
(5) |
|||||||||||
Consolidated |
$ |
962,487 |
$ |
573,939 |
$ |
3,231,616 |
$ |
2,147,128 |
|||||||
Underwriting Segment Combined Ratios |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Excess and Surplus Lines |
78 |
% |
102 |
% |
80 |
% |
94 |
% |
|||||||
Specialty Admitted |
88 |
% |
107 |
% |
97 |
% |
108 |
% |
|||||||
London Insurance Market |
87 |
% |
92 |
% |
88 |
% |
89 |
% |
|||||||
Alterra |
119 |
% |
— |
% |
118 |
% |
— |
% |
|||||||
Consolidated |
96 |
% |
100 |
% |
97 |
% |
97 |
% |
|||||||
Reconciliation of Segment Profit (Loss) to Consolidated Operating Income |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Excess and Surplus Lines (1) |
$ |
51,132 |
$ |
(4,765) |
$ |
171,508 |
$ |
50,141 |
|||||||
Specialty Admitted (1) |
24,604 |
(9,011) |
17,959 |
(43,293) |
|||||||||||
London Insurance Market (1) |
24,810 |
15,362 |
95,430 |
82,663 |
|||||||||||
Alterra (1) |
(58,556) |
— |
(150,224) |
— |
|||||||||||
Other Insurance (Discontinued Lines) (1) |
(13,514) |
(1,063) |
(57,426) |
(21,283) |
|||||||||||
Investing |
111,036 |
80,510 |
380,525 |
313,700 |
|||||||||||
Other Revenues (Markel Ventures) |
200,226 |
144,392 |
686,448 |
489,352 |
|||||||||||
Other Expenses (Markel Ventures) |
(184,856) |
(127,400) |
(613,250) |
(432,956) |
|||||||||||
Amortization of Intangible Assets |
(17,468) |
(8,434) |
(55,223) |
(33,512) |
|||||||||||
Consolidated |
$ |
137,414 |
$ |
89,591 |
$ |
475,747 |
$ |
404,812 |
(1) Segment profit (loss) for our underwriting segments includes underwriting profit (loss) as well as other revenues and other expenses from our insurance operations.
Other Revenues |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Other Revenues (Insurance) |
|||||||||||||||
Managing general agent operations |
$ |
1,638 |
$ |
8,671 |
$ |
17,399 |
$ |
48,056 |
|||||||
Life and annuity |
651 |
— |
1,130 |
— |
|||||||||||
Other |
3,747 |
443 |
5,965 |
1,876 |
|||||||||||
Insurance Other Revenues |
6,036 |
9,114 |
24,494 |
49,932 |
|||||||||||
Other Revenues (Markel Ventures) |
|||||||||||||||
Manufacturing |
113,871 |
111,321 |
495,138 |
366,886 |
|||||||||||
Non-Manufacturing |
86,355 |
33,071 |
191,310 |
122,466 |
|||||||||||
Markel Ventures Other Revenues |
200,226 |
144,392 |
686,448 |
489,352 |
|||||||||||
Consolidated Other Revenues |
$ |
206,262 |
$ |
153,506 |
$ |
710,942 |
$ |
539,284 |
Other Expenses |
|||||||||||||||
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Other Expenses (Insurance) |
|||||||||||||||
Managing general agent operations |
$ |
3,533 |
$ |
6,892 |
$ |
20,382 |
$ |
43,069 |
|||||||
Life and annuity |
15,087 |
— |
28,126 |
— |
|||||||||||
Other |
410 |
494 |
1,770 |
2,223 |
|||||||||||
Insurance Other Expenses |
19,030 |
7,386 |
50,278 |
45,292 |
|||||||||||
Other Expenses (Markel Ventures) |
|||||||||||||||
Manufacturing |
101,781 |
102,256 |
437,712 |
328,484 |
|||||||||||
Non-Manufacturing |
83,075 |
25,144 |
175,538 |
104,472 |
|||||||||||
Markel Ventures Other Expenses |
184,856 |
127,400 |
613,250 |
432,956 |
|||||||||||
Consolidated Other Expenses |
$ |
203,886 |
$ |
134,786 |
$ |
663,528 |
$ |
478,248 |
Reconciliation of Non-GAAP Financial Measure
The following table reconciles earnings before interest, income taxes, depreciation and amortization (EBITDA) of
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(dollars in thousands) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Markel Ventures EBITDA |
$ |
19,546 |
$ |
18,980 |
$ |
83,787 |
$ |
60,361 |
|||||||
Interest expense |
(2,274) |
(2,233) |
(9,283) |
(9,782) |
|||||||||||
Income tax expense |
(1,957) |
(3,036) |
(13,988) |
(7,868) |
|||||||||||
Depreciation expense |
(5,185) |
(4,738) |
(19,313) |
(14,205) |
|||||||||||
Amortization of intangible assets |
(4,481) |
(4,076) |
(17,383) |
(15,031) |
|||||||||||
Markel Ventures net income to shareholders |
5,649 |
4,897 |
23,820 |
13,475 |
|||||||||||
Net income from other Markel operations |
93,115 |
51,895 |
257,201 |
239,910 |
|||||||||||
Net income to shareholders |
$ |
98,764 |
$ |
56,792 |
$ |
281,021 |
$ |
253,385 |
Interest expense for the quarters ended
Markel Ventures EBITDA is a non-GAAP financial measure and is reconciled to consolidated net income to shareholders in the above table. Markel Ventures EBITDA reflects income attributable to our ownership interest in
Net Income per Share
Net income per share was determined by dividing adjusted net income to shareholders by the applicable weighted average shares outstanding. Unvested share-based compensation awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are considered participating awards and are included in the computation of net income per share. Non-participating unvested share-based compensation awards are excluded from the computation of net income per share. Diluted net income per share is computed by dividing adjusted net income to shareholders by the weighted average number of common shares and dilutive potential common shares outstanding during the year.
Quarters Ended December 31, |
Years Ended December 31, |
||||||||||||||
(in thousands, except per share amounts) |
2013 |
2012 |
2013 |
2012 |
|||||||||||
Net income to shareholders |
$ |
98,764 |
$ |
56,792 |
$ |
281,021 |
$ |
253,385 |
|||||||
Adjustment of redeemable noncontrolling interests |
(1,138) |
3,383 |
1,963 |
(3,101) |
|||||||||||
Adjusted net income to shareholders |
$ |
97,626 |
$ |
60,175 |
$ |
282,984 |
$ |
250,284 |
|||||||
Basic common shares outstanding |
13,987 |
9,635 |
12,538 |
9,640 |
|||||||||||
Dilutive potential common shares from conversion of options |
14 |
3 |
12 |
6 |
|||||||||||
Dilutive potential common shares from conversion of |
48 |
27 |
36 |
20 |
|||||||||||
Diluted shares outstanding |
14,049 |
9,665 |
12,586 |
9,666 |
|||||||||||
Basic net income per share |
$ |
6.98 |
$ |
6.25 |
$ |
22.57 |
$ |
25.96 |
|||||||
Diluted net income per share |
$ |
6.95 |
$ |
6.23 |
$ |
22.48 |
$ |
25.89 |
SOURCE
Bruce Kay, Markel Corporation, 804-747-0136, bkay@markelcorp.com